AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 OCT 7 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has granted Instead, Inc. clearance to market its personal lubricant product, Amphora.
In addition to its lubricating properties, Amphora has been shown, in early clinical and pre-clinical tests, to immobilize sperm for up to 8 hours when applied vaginally by women, and, in laboratory testing, to inactivate certain sexually transmitted infection-causing organisms including gonococci (gonorrhea), herpes, chlamydia, and HIV.
Instead vice president and general manager, Teri Hirschfeld, said that while demonstrating the effectiveness of Amphora's microbicidal properties will require full-scale clinical trials that will take years to conduct, the company hopes to receive clearance to market a new contraceptive device utilizing Amphora in the very near future.
Amphora (clinically known as Acidform) is an "acid-buffering" gel that coats the vaginal wall and cervix to maintain a woman's natural pH level between 3.8 and 4.2. It is also compatible with latex ...
Source: HighBeam Research, Personal protective lubricant for women cleared by U.S. FDA for...